Call for Submissions
Blog The John Grube Foundation e.V., based in Hamburg, awards the “John Grube Prize” in honour of its namesake, who died young of granulomatosis with polyangiitis (GPA). The DGRH has been involved in the award since 2021 by appointing a board member to the foundation’s advisory board and providing a platform and a worthy setting […]
Amgen Successfully Completes Acquisition of ChemoCentryx
Blog TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders […]
US FDA approves Regeneron-Sanofi’s Kevzara to treat polymyalgia rheumatica
Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult patients. Kevzara has been approved as the first and only biologic indicated for PMR adult patients who did not respond to corticosteroids or who cannot tolerate corticosteroid taper. Developed using […]
Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
Blog First head-to-head trial of biologics in EGPA, comparing a single monthly injection of Fasenra to three injections per month of mepolizumab Positive high-level results from the MANDARA Phase III trial showed AstraZeneca’s Fasenra (benralizumab) met the primary endpoint of the trial and demonstrated non-inferior rates of remission compared to mepolizumab in patients with eosinophilic […]
VPPRN 6-Month Check-in Forms – Community Dashboard
Blog 6-Month Check-In Forms VPPRN Community Dashboard | January 2023 Take a look below at what we learned from the VPPRN community about FATIGUE, PAIN, FLARES and SYMPTOMS OF VASCULITIS at the January 2023 check-in. What did we learn about FATIGUE and VASCULITIS? We learned that most patients (over 88%) experience some fatigue related to their […]
Mom Climbs Highest Mountain in Africa in Memory of Her Extraordinary Daughter
Blog Update: Jo has made it to the top of Mt. Kilimanjaro! The climb was by far the hardest thing she’s ever had to face other than losing her daughter, Amy, to vasculitis. “They call it ‘The Roof of Africa’ but I call it almost to heaven! It’s the closest I’ll be to Amy until […]
Announcing Our 2022 VF Patient Heroes
Blog Announcing the 2022 Patient Heroes Ordinary people can become extraordinary in their journey through life — and this has never been truer than it is today. Look around and you’ll see that there are everyday heroes living among us. That’s why this Vasculitis Awareness Month, the VF will be highlighting a few of the […]
2022 V-RED Winners
Blog There’s something unique about the Vasculitis Foundation’s (VF’s) 2022 Recognizing Excellence in Diagnostics (V-RED) award program: We have two winners who tied for first place and two winners who received honorable mentions. Now in its ninth year, the V-RED award program calls on patients worldwide to nominate a medical professional they want to recognize […]
VF Board of Directors Welcomes Nona Bear
Blog Nona is a nationally known advocate of healthcare reform and champion of seniors’ issues. Originally an academic who served on the faculties of several Washington-area universities including American, Howard, and George Mason, she was hired to establish a continuing education program at the U.S. Soldiers’ and Airmen’s Home, a facility serving thousands of military […]
VPPRN Vasculitis and ANCA Workshop Research Abstract
Blog Vasculitis and ANCA Workshop | April 2022 | Dublin, Ireland As part of the 20th International Vasculitis and ANCA Workshop, our investigators examined changes in anxiety and interruptions in the use of immunosuppression medications among patients with vasculitis during the COVID-19 pandemic, along with the reasons for such medication interruptions. Take a look at […]